(Q27687082)

English

FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials (English)
1 reference
K. M. F. Itani
1 reference
A. F. Shorr
1 reference
January 2014
1 reference
58 Suppl 1
1 reference
S4-9
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit